| Type: |
Conjugated Primary Antibody |
| Conjugated with: |
594, ALEXA FLUOR® |
| Host organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Protein/Peptide: |
H1N1 Matrix Protein 1 |
| Specificity: |
This antibody reacts specifically with H1N1 Matrix Protein 1 |
| Modification: |
No modification has been applied to this antibody |
| Modification site: |
None |
| Clonality: |
Polyclonal Antibody |
| Clone: |
Polyclonal Antibodies |
| Concentration: |
1ug per 1ul |
| Antigen Source: |
KLH conjugated synthetic peptide derived from H1N1 Matrix Protein 1 |
| Applications: |
IF(IHC-P) |
| Applications with corresponding dilutions: |
IF(IHC-P)(1:50-200) |
| Cross reactive species: |
Virus |
| Cross Reactive Species details: |
Influenza A virus H1N1 |
| Background information: |
During 1997, HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues, Influenza A can exist in a variety of animals, Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, There was some evidence of human to human spread of this virus, These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes, Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong, but it is thought that the transmission efficiency was fairly low, however it is in birds that all subtypes can be found, indicating its species jumping ability, resulting in devastating pandemics, Influenza A virus is a major public health threat |
| Purification method: |
Purified by Protein A |
| Storage: |
50% glycerol and 0, Store at 4°, 09% sodium azide, C for 12 months, Water buffered solution containing 100ug/ml BSA |
| Excitation emission: |
590nm/617nm |
| Synonyms: |
H1N1 M1, Influenza A virus A/Calornia/04/2009H1N1Matrix Protein-1 |
| Also known as: |
H1N1 Matrix Protein 1 Antibody |
| Other name: |
Anti-H1N1 Matrix Protein 1 |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, specificity and sensitivity, thus reducing its reactivity, Avoid freeze/thaw cycles as they may denaturate the polypeptide chains of the antibody |
| Properties: |
For facs or microscopy Alexa 1 conjugate |
| Conjugation: |
Alexa Fluor |
| Gene target: |
H1N1 Matrix Protein 1 |
| Short name: |
Fluor 594, Anti-H1N1 Matrix Protein 1 |
| Label: |
ALEXA |
| Alternative name: |
ALEXA Fluor 594, antibody to-H1N1 Matrix Protein 1 |